This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (27)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Endophthalmitis  • Articles for Residents  • Alert me on articles by topic

Seenu M. Hariprasad, MD; Kevin J. Blinder, MD; Gaurav K. Shah, MD; Rajendra S. Apte, MD, PhD; Brett Rosenblatt, MD; Nancy M. Holekamp, MD; Matthew A. Thomas, MD; William F. Mieler, MD; Jingduan Chi, PhD; Randall A. Prince, PharmD

Arch Ophthalmol. 2005;123:39-44.

Objective  To investigate the penetration of 0.5% moxifloxacin hydrochloride into the aqueous and vitreous after topical administration in humans.

Methods  A prospective, nonrandomized study of 20 patients scheduled for vitrectomy surgery between September 1 and December 31, 2003. Aqueous and vitreous samples were obtained and analyzed after topical administration of 0.5% moxifloxacin hydrochloride, every 2 hours (q2h) or every 6 hours (q6h), for 3 days before surgery. Assays were performed using high-performance liquid chromatography.

Results  Mean ± SD moxifloxacin concentrations in the q2h group for the aqueous (n = 9) and vitreous (n = 10) were 2.28 ± 1.23 and 0.11 ± 0.05 µg/mL, respectively. Mean ± SD moxifloxacin concentrations in the q6h group for the aqueous (n = 10) and vitreous (n = 9) were 0.88 ± 0.88 and 0.06 ± 0.06 µg/mL, respectively. The minimum inhibitory concentration for 90% of isolates (MIC₉₀) was far exceeded in the aqueous for a wide spectrum of key pathogens, whereas it was not exceeded in the vitreous for several organisms. However, the minimum inhibitory concentration for 50% of the isolates was exceeded in the q2h vitreous group for Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Bacillus cereus, and other gram-negative pathogens.

Conclusions  The Endophthalmitis Vitrectomy Study revealed that 94.2% of isolates from postoperative endophthalmitis are gram-positive pathogens. Moxifloxacin has a spectrum of coverage that appropriately encompasses the most common organisms in endophthalmitis. The pharmacokinetic findings of this investigation show that relatively high aqueous levels can be achieved after topical administration. Further studies will help define the precise role of 0.5% moxifloxacin ophthalmic solution in the treatment of or prophylaxis against intraocular infections.

Author Affiliations: Barnes Retina Institute, Department of Ophthalmology and Visual Science, Washington University School of Medicine, St Louis, Mo (Drs Hariprasad, Blinder, Shah, Apte, Rosenblatt, Holekamp, and Thomas); Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Ill (Dr Mieler); and College of Pharmacy, University of Houston, Houston, Tex (Drs Chi and Prince).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phakic status affects vitreous penetration of topical moxifloxacin.
Fuller and McGwin
Arch Ophthalmol 2006;124:749-749.
FULL TEXT  

Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
Gao et al.
IOVS 2006;47:1606-1611.
ABSTRACT | FULL TEXT  

In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates.
Miller et al.
Arch Ophthalmol 2006;124:479-483.
ABSTRACT | FULL TEXT  

Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Hariprasad et al.
Arch Ophthalmol 2006;124:178-182.
ABSTRACT | FULL TEXT